Building the Foundation of Discovery
We collaborate with specialized preclinical research organizations that provide expertise in pharmacology, toxicology, bioanalytical testing, and related disciplines. These collaborations are designed to support scientific rigor, quality, and regulatory readiness as our programs advance through preclinical development.
Partnerships Fueling Innovation and Research
Strategic collaborations expand our scientific capabilities and provide access to specialized expertise, technologies, and research infrastructure. By working with leading organizations and scientific experts, we aim to accelerate the evaluation and development of our peptide portfolio.
Strategic partnerships advancing our science
Preparing for Clinical Translation
As our programs advance, we intend to collaborate with experienced clinical, regulatory, and data organizations to support the transition from preclinical research to clinical development. These future collaborations are expected to support patient safety, data integrity, regulatory readiness, and operational excellence.
AI-Enabled Peptide Discovery and Optimization
AI-driven design, molecular modeling, and computational tools are creating new opportunities in peptide drug discovery. We intend to leverage these technologies to support the identification, evaluation, and optimization of peptide candidates, helping prioritize compounds for synthesis and experimental testing.
Partnering for a healthier future
By aligning with industry leaders and adopting cutting edge technology, Aqur is positioned to bring transformative cholesterol therapies to millions worldwide. Our partnerships are more than collaborations — they are key drivers of medical breakthroughs. Together, we are shaping the future of cardiovascular health.
